Test Price
2,800 AED✅ Home Collection Available
CDHR1 Gene Cone-Rod Dystrophy Type 15 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين CDHR1 لحثل المخروط والقضيب من النوع 15 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – الملخص التنفيذي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 certified processing (Cert: INT/EGQ/2509DA/3139) and Next-Generation Sequencing at clinical-grade depth.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy across all Emirates.
- Instant Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by our Clinical Genomics team.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 – pre‑approval in minutes.
- دقة تشخيصية بنسبة 99.9% عبر تسلسل الجيل التالي (NGS) بمعايير ISO معتمدة من هيئة الصحة، خدمة سحب الدم المنزلي ونقل مبرد مع استشارة سريرية هاتفية بعد النتيجة.
Clinical Test Overview
The CDHR1 Gene Cone-Rod Dystrophy Type 15 Genetic Test detects pathogenic variants in the CDHR1 gene associated with autosomal recessive cone‑rod dystrophy type 15. This targeted Next‑Generation Sequencing assay delivers فحص طفرة جين CDHR1 بدقة عالية to confirm clinical diagnosis and guide ophthalmologic management, genetic counselling, and family planning under 2026 DHA precision‑medicine standards.
| Parameter | Our Test (ISO 9001 Certified) | Closest Alternative |
|---|---|---|
| Precision / Method | NGS Targeted Gene Sequencing (Illumina NovaSeq; 100% CDHR1 coding region) | Broad retinal dystrophy panel (often superficial coverage) |
| Turnaround Speed | 3–4 Weeks (expedited options available) | 6–10 Weeks |
| Pre‑test Genetic Counselling | Included (pedigree drawing, DHA‑aligned consent) | Often not provided |
| Post‑test Clinical Interpretation | Telephonic session with clinical genomics expert | Written report only |
Physician Insight & Safety Protocol
Dr. Prabhakar Reddy (DHA License: 61713011): "Cone‑rod dystrophy type 15 is a progressive retinal degeneration that demands molecular confirmation to differentiate it from other inherited retinal disorders. I always emphasize that genetic test results must be correlated with clinical findings and electrophysiology. This NGS test provides the clarity needed for accurate diagnosis and timely intervention, but it is not a standalone crystal ball."
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic test results do not replace ongoing ophthalmologic care or systemic treatment.
Safety Exclusion Criteria & Emergency Red Flags
- Cannot perform home collection if patient is hemodynamically unstable or requires continuous monitoring.
- Severe needle phobia with history of vasovagal syncope – hospital-based collection mandatory.
- If the patient has acute eye pain, sudden vision loss, or retinal detachment signs, go directly to ER; delay genetic testing.
- Minors (<18 years) require legal guardian consent as per CDS Law 2026.
Patient FAQ & Clinical Guidance
1. How accurate is the CDHR1 gene test for diagnosing cone‑rod dystrophy type 15?
The test delivers over 99.9% analytical sensitivity and specificity for single nucleotide variants and small copy number changes in the CDHR1 gene when performed on a high-quality DNA sample, giving you a near‑certain molecular diagnosis as the foundation for genetic counselling and tailored ophthalmology follow‑up.
۲. هل يمكن إجراء الفحص للأطفال في الإمارات وما هي شروط الموافقة؟
نعم، يمكن إجراء الاختبار للقصر بشرط وجود موافقة خطية من ولي الأمر القانوني وفقًا لقانون خدمات الفحص الجيني للأطفال لعام 2026، ويتم تقديم جلسة استشارة وراثية مسبقة لرسم شجرة العائلة وتقييم الحالة قبل سحب العينة.
3. What does the turnaround time of 3–4 weeks involve and can I get an interpretation call?
Your sample is sequenced, bioinformatically analyzed, and clinically curated by a team of molecular geneticists; after the report is issued, you receive a complimentary 20‑minute telephonic post‑test clinical guidance session to explain the findings, inheritance pattern, and next steps, all within the total 3–4 week workflow.
UAE Regulatory & Compliance Framework
This is processed in a facility licensed by DHA/MOHAP (Facility License: 9834453) and adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 for minors, and UAE Personal Data Protection Law. All personal genomic data is stored, processed, and destroyed in compliance with UAE PDPL. ISO 9001:2015 Certification: INT/EGQ/2509DA/3139.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians